Investment Summary |
|
|---|---|
| Date | 2024-04-18 |
| Target | Bio Insumos Nativa |
| Sector | Agriculture |
| Investor(s) | Sumitomo |
| Deal Type | Growth Capital |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1919 |
| Sector | Distribution |
| Employees | 74,920 |
| Revenue | 5,495.0B JPY (2022) |
Sumitomo is a global network and based on trust from companies in various industries and from consumers, Sumitomo Corporation engages in multifaceted business activities by making the most of its Integrated Corporate Strength. These business activities include sales of a variety of products and services within Japan, import and export, trilateral trade, and domestic and international business investment. Sumitomo was founded in 1919 and is based in Tokyo, Japan.
| DEAL STATS | # |
|---|---|
| Overall | 41 of 41 |
| Sector (Agriculture) | 2 of 2 |
| Type (Growth Capital) | 4 of 4 |
| Country (Chile) | 2 of 2 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-01-17 |
Upsher-Smith Laboratories
Maple Grove, Minnesota, United States Upsher-Smith Laboratories is a pharmaceutical company, that delivers quality therapies and solutions that measurably improve individuals’ lives. Upsher-Smith Laboratories is based in Maple Grove, Minnesota. |
Sell | - |
